Info Wvc
Toluidine blue staining of BM smears requires 5 min. Staining requires 45 min, and instruments may be set up during this time. The dead time for the acquisition of the samples, both in the basic and support protocols, depends on the mast cell frequencies in the BM specimens and can vary from 1 to 7 min per tube.
Literature Cited
Cerveró, C., Escribano, L., Orfao, A., Díaz Agustín, B., Bravo, P., Villarrubia, J., García-Sanz, R., Velasco, J.L., Herrera, P., Vargas, M., et al. 1999. Expression of bcl-2 by human bone marrow mast cells and its overexpression in mast cell leukemia. Am. J. Hematol. 60:191-195.
Ciudad, J., San Miguel, J.F., López-Berges, M.C., Vidríales, B., Valverde, B., Ocqueteau, M., Mateos, G., Caballero, M.D., Hernández, J., Moro, M.J., et al. 1998. Prognostic value of immunophenotypic detection of minimal residual disease in acute lymphoblastic leukemia. J. Clin. Oncol. 16:3774-3781.
Díaz Agustín, B., Escribano, L., Bravo, P., Herrero, S., Nuñez, R., Navalón, R., Torrelo, A., Can-talapiedra, A., Del Castillo, L., Villarrubia, J., et al. 1999. The CD69 early activation molecule is overexpressed in human bone marrow mast cells from adults with indolent systemic mast cell disease. Br. J. Haematol. 106:400-405.
Escribano, L., Orfao, A., Villarrubia, J., Cerveró, C., Velasco, J.L., Martin, F., San Miguel, J.F., and Navarro, J.L. 1995. Expression of lymphoid-as-sociated antigens in mast cells: Report of a case of systemic mast cell disease. Br. J. Haematol. 91:941-943.
Escribano, L., Orfao, A., Villarrubia, J., Martín, F., Madruga, J.I., Cuevas, M., Velasco, J.L., Rios, A., and San Miguel, J.F. 1997a. Sequential im-munophenotypic analysis of mast cells in a case of systemic mast cell disease evolving to a mast cell leukemia. Cytometry 30:98-102.
Escribano, L., Orfao, A., Díaz Agustín, B., Villarrubia, J., Cerveró, C., López, A., García Marcos, A., Bellas, C., Fernández Cañadas, S., Cuevas, M., et al. 1997b. Indolent systemic mast cell disease in adults. Immunophenotypic characterization and its diagnostic implications. Blood 91:2731-2736.
Escribano, L., Orfao, A., Villarrubia, J., Díaz Agustín, B., Cerveró, C., Ríos, A., Velasco, J.L., Ciudad, J., Navarro, J.L., and San Miguel, J.F. 1998. Immunophenotypic characterization of human bone marrow mast cells: A flow cytomet-ric study of normal and pathological bone marrow samples. Ann. Cell. Pathol. 16:151-159.
Escribano, L., Díaz Agustín, B., Bravo, P., Navalón, R., Almeida, J., and Orfao, A. 1999. Immuno-phenotype of bone marrow mast cells in indolent systemic mast cell disease in adults. Leuk. Lymphoma 35:227-235.
Gross, H.J., Verwer, B., Houck, D., and Reckten-wald, D. 1993. Detection of rare cells at a frequency of one per million by flow cytometry. Cytometry 14:519-526.
Johnstone, J.M. 1954. The appearance and significance of tissue mast cells in the human bone marrow. J. Clin. Pathol. 7:275-280.
Kitamura, Y., Shimada, M., Hatanaka, K., and Miy-ano, Y. 1977. Development of mast cells from grafted bone marrow cells in irradiated mice. Nature 268:442-443.
Kitamura, Y., Go, S., and Hatanaka, K. 1978. Decrease of mast cells in W/Wv mice and their increase by bone marrow transplantation. Blood 52:447-452.
Kitamura, Y., Hatanaka, K., Murakami, M., and Shibata, H. 1979. Presence of mast cells precursors in peripheral blood of mice demonstrated by parabiosis. Blood 53:1085-1088.
Macedo, A., Orfao, A., Martínez, A., Vidriales, M.B., Valverde, B., López-Berges, M.C., and San Miguel, J.F. 1995. Immunophenotype of c-kit cells in normal human bone marrow: Implications for the detection of minimal residual disease in AML. Br. J. Haematol. 89:338-341.
McKenna, M.J. 1994. Histomorphometric study of mast cells in normal bone, osteoporosis, and mastocytosis using a new stain. Calcif. Tissue Int. 55:257-259.
Orfao, A., Ciudad, J., Lopez-Berges, M.C., Lopez, A., Vidriales, B., Caballero, M.D., Valverde, B., Gonzalez, M., and San Miguel, J.F. 1994. Acute lymphoblastic leukemia (ALL): Detection of minimal residual disease (MRD) at flow cy-tometry. Leuk. Lymphoma 13 Suppl. 1:87-90.
Orfao, A., Escribano, L., Villarrubia, J., Velasco, J.L., Cerveró, C., Ciudad, J., Navarro, J.L., and San Miguel, J.F. 1996. Flow cytometric analysis of mast cells from normal and pathological human bone marrow samples. Identification and enumeration. Am. J. Pathol. 149:1493-1499.
Prokocimer, M. and Polliack, A. 1981. Increased bone marrow mast cells in preleukemic syndromes, acute leukemia, and lymphoprolifera-tive disorders. Am. J. Clin. Pathol. 75:34-38.
Sale, G.E. and Marmont, P. 1981. Marrow mast cell counts do not predict bone marrow graft rejection. Hum. Pathol. 12:605-608.
San Miguel, J.F., Martínez, A., Macedo, A., Vidriales, M.B., López-Berges, C., González, M., Cabaliero, D., García-Marcos, M.A., Ramos, F., Fernández-Calvo, J., et al. 1997. Immunopheno-typing investigation of minimal residual disease is a useful approach for predicting relapse in acute myeloid leukemia patients. Blood 90:2465-2470.
Phenotypic Analysis
Post a comment